{"name":"Michael Tsoukas","slug":"michael-tsoukas","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiT0FVX3lxTFBSSlZESzJMVjNSc3Y2ZjlxSS1iVVNTbHUwcjR4eTNnbHRzWElucmJuRS1aMF9TTS1ja0FKZVMzZFFvekVDN1h3QnF5a29vSDA?oc=5","date":"2026-02-23","type":"pipeline","source":"CMAJ","summary":"Cost-effectiveness of sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists for patients with high cardiovascular risk and type 2 diabetes in Canada - CMAJ","headline":"Cost-effectiveness of sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists for patien","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOYUtjRTFEa3JoYjNXUTFVY1JiZ3dKSDEyUVJHckRDbzRqUjY3dWVyT3BXS3FZRloyVXFHbS1SenhYeS1ZT0ZLYkp6QmlrbExMcEhXb0JjcExQOXA5MWs0ZnU1cG82LVJaT190S2Z4STU2Snd5QW9mYVFjeTdYY0xJTWR1UVlBRFBWa2VTSFdadTFvbFFqU0h2T19jdjhZVWluampBSA?oc=5","date":"2026-01-07","type":"patent","source":"Montreal Gazette","summary":"Why generic Ozempic could soon become a lot cheaper in Quebec - Montreal Gazette","headline":"Why generic Ozempic could soon become a lot cheaper in Quebec","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE9LT0xWb09VQjlaZUtpQ2lyZVMxWmx5cWNzNDRYV0JxajhtdFdKaVg4VmpqOHJ4aVJQSlM3SllqRzhpczdwYXd4NkM3NWxsd2VtZUQzNExFYXhjUmx6WDU4?oc=5","date":"2025-01-10","type":"regulatory","source":"Nature","summary":"Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossover trial - Nature","headline":"Subcutaneous weekly semaglutide with automated insulin delivery in type 1 diabetes: a double-blind, randomized, crossove","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}